Articles |
From the Rammelkamp Center for Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio; the Department of Physiology, Baylor College of Medicine, Houston, Tex; and the Department of Neuroscience Section of Pharmacology (M.T.), Second School of Medicine, University of Naples, Italy.
Correspondence to A.M. Brown, Rammelkamp Center, 2500 MetroHealth Drive, Cleveland, OH 44109-1998.
Abstract Methanesulfonanilide derivatives such as dofetilide are members of the widely used Class III group of cardiac antiarrhythmic drugs. A methanesulfonanilide-sensitive cardiac current has been identified as IKr, the rapidly activating component of the repolarizing outward cardiac K+ current, IK. IKr may be encoded by the human ether-related gene (hERG), which belongs to the family of voltage-dependent K+ (Kv) channels having six putative transmembrane segments. The hERG also expresses an inwardly rectifying, methanesulfonanilide-sensitive K+ current. Here we show that hIRK, a member of the two-transmembrane-segment family of inward K+ rectifiers that we have cloned from human heart, is a target for dofetilide. hIRK currents, expressed heterologously in Xenopus oocytes, are blocked by dofetilide at submicromolar concentrations (IC50=533 nmol/L at 40 mV and 20°C). The drug has no significant blocking effect on the human cardiac Kv channels hKv1.2, hKv1.4, hKv1.5, or hKv2.1. The block is voltage dependent, use dependent, and shortens open times in a manner consistent with open-channel block. While steady state block is strongest at depolarized potentials, recovery from block is very slow even at hyperpolarized potentials (tau=1.17 seconds at -80 mV). Thus, block of hIRK may persist during diastole and might thereby affect cardiac excitability.
Key Words: human inward rectifier K+ channel Class III antiarrhythmic drugs dofetilide IKr
This article has been cited by other articles:
![]() |
W. Hirdes, L. F. Horowitz, and B. Hille Muscarinic modulation of erg potassium current J. Physiol., August 15, 2004; 559(1): 67 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Cayabyab, F. W. L. Tsui, and L. C. Schlichter Modulation of the ERG K+ Current by the Tyrosine Phosphatase, SHP-1 J. Biol. Chem., December 6, 2002; 277(50): 48130 - 48138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Karle, E. Zitron, W. Zhang, G. Wendt-Nordahl, S. Kathofer, D. Thomas, B. Gut, E. Scholz, C.-F. Vahl, H. A. Katus, et al. Human Cardiac Inwardly-Rectifying K+ Channel Kir2.1b Is Inhibited by Direct Protein Kinase C-Dependent Regulation in Human Isolated Cardiomyocytes and in an Expression System Circulation, September 17, 2002; 106(12): 1493 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Park, H. Choe, Y.-K. Lee, K.-C. Ha, K.-S. Rhee, J.-K. Ko, C.-U. Joo, S.-W. Chae, and Y.-G. Kwak Open Channel Block by KCB-328 [1-(2-Amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane Hydrochloride] of the Heterologously Expressed Human Ether-a-go-go-Related Gene K+ Channels J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Karle, V. A.W Kreye, D. Thomas, K. Rockl, S. Kathofer, W. Zhang, and J. Kiehn Antiarrhythmic drug carvedilol inhibits HERG potassium channels Cardiovasc Res, February 1, 2001; 49(2): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lee and E. W. Lee Ionic Mechanism of Ibutilide in Human Atrium: Evidence for a Drug-Induced Na+ Current Through a Nifedipine Inhibited Inward Channel J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 9 - 22. [Abstract] [Full Text] |
||||
![]() |
J. Kiehn, A. E. Lacerda, B. Wible, and A. M. Brown Molecular Physiology and Pharmacology of HERG: Single-Channel Currents and Block by Dofetilide Circulation, November 15, 1996; 94(10): 2572 - 2579. [Abstract] [Full Text] |
||||
![]() |
Z. Wang, J. Kiehn, Q. Yang, A. M. Brown, and B. A. Wible Comparison of Binding and Block Produced by Alternatively Spliced Kvbeta 1 Subunits J. Biol. Chem., November 8, 1996; 271(45): 28311 - 28317. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |